Biote (BTMD) Cash from Financing Activities (2021 - 2026)

Biote has reported Cash from Financing Activities for 6 years, with the latest figure at -$21.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities fell 854.32% year-over-year to -$21.5 million; the trailing twelve-month figure through Mar 2026 stood at -$62.8 million (up 13.84% YoY), and the FY2025 full-year result was -$43.6 million, up 42.75% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$21.5 million, down from -$9.1 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $84.3 million in Q2 2022, with the low at -$59.0 million in Q2 2024.
• Average Cash from Financing Activities over 5 years is -$5.4 million, with a median of -$5.1 million recorded in 2023.
• Year-over-year, Cash from Financing Activities soared 125.57% in 2022 and tumbled 1065.92% in 2024.
• Tracing BTMD's Cash from Financing Activities over 5 years: stood at -$4.0 million in 2022, then surged by 36.49% to -$2.5 million in 2023, then slumped by 293.43% to -$9.9 million in 2024, then advanced by 8.08% to -$9.1 million in 2025, then tumbled by 135.89% to -$21.5 million in 2026.
• The last three Cash from Financing Activities figures came in at -$21.5 million (Q1 2026), -$9.1 million (Q4 2025), and -$4.9 million (Q3 2025), per Business Quant data.

Peer Comparison